MYC and breast carcinoma: In ER+ breast cancer, similarly, MYC overexpressed tumours with low ATM levels were associated with worse survival (p < 0.001) (Fig. 2b, e) including in patients who received endocrine therapy (Supplementary Figs. S3B and S3F).